Hot Products
| Catalog No. | Information |
| CFN91669 | Celosin H Celosin H is a novel hepatoprotective triterpenoid saponin isolated from the methanol extract of Celosiae Semen. |
| CFN91061 | Celosin I Celosin H, celosin I, and celosin J could be used as chemical markers for the quality control of C. argentea seeds. Celosin I exhibited significant hepatoprotective effect on carbon tetrachloride-induced and N,N-dimethylformamide-induced hepatotoxicity in mice. |
| CFN90433 | Centaureidin Centaureidin augments IFN-gamma promoter activity by approximately four-fold. Centaureidin shows potential vasorelaxant activity. It inhibits dendrite outgrowth from melanocytes by activating Rho, resulting in the inhibition of melanosome transfer from melanocytes to keratinocytes. |
| CFN98383 | Centrolobol (-)-Centrolobol has antifibrotic activity, it can significantly inhibit the proliferation of HSC-T6 cells in a dose-dependent manner. Centrolobol exhibits strong cytotoxic activity against KB cell line. |
| CFN93317 | Cephaeline Cephaeline was highly active against protected primary CLL cells (relative IC50's 35 nM ) and acted by repressing HIF-1α and disturbing intracellular redox homeostasis. |
| CFN70419 | Cephaeline dihydrobromide Reference standards. |
| CFN98518 | Cephalomannine Cephalomannine is a taxol derivative with antitumor, antiproliferative properties, it shows cytotoxicity in human glial and neuroblastoma cell-lines. |
| CFN90919 | Cephalotaxine Cephalotaxine is an antiviral as well as antitumor agent. It is useless for the treatment of infection by flaviviruses, but potentially useful in combined therapy against hepatitis B. |
| CFN96041 | Cepharadione A Cepharadione A is a naturally occurring DNA damaging agent. |
| CFN98570 | Cepharanthine Cepharanthine has anti-plasmodial, anti-tumor , anti-inflammatory, antiallergic, antioxidant, and immunomodulatory activities in vivo, and it is a highly potent inhibitor of HIV-1 replication in a chronically infected monocytic cell line. Cepharanthine inhibits the HIV-1 entry process by reducing plasma membrane fluidity, and the plasma membrane is therefore an identical target to prevent viral infection. |
